msaouel

Pavlos Msaouel, M.D., Ph.D.

Picture

Pavlos Msaouel, M.D., Ph.D.

Research Observer

Email

pmsaouel@mdanderson.org

Positions

Research Observer: Mol and Cell Biology-Walker
Baylor College of Medicine
Houston, TX US

Assistant Professor: Genitourinary Medical Oncology
Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas United States
Medical Oncologist specializing in the treatment of genitourinary malignancies

Education

MD from University of Athens School of Medicine: 10/2006 - Athens, Greece

PhD from University of Athens School of Medicine,: 11/2011 - Athens, Greece; Cellular physiology and neoplasm research

Research Fellowship at Mayo Clinic: 07/2009 - Rochester, Minnesota United States; Oncolytic Virotherapy

Residency at Jacobi Medical Center, Albert / Einstein College of Medicine: 06/2014 - New York, New York United States

Residency at Jacobi Medical Center, Albert / Einstein College of Medicine: 06/2015 - New York, New York United States; Chief resident

Clinical Fellowship at The University of Texas MD Anderson Cancer Center: 06/2018 - Houston, United States

Certifications

Internal Medicine: American Board of Internal Medicine

Medical Oncology: American Board of Internal Medicine - Medical Oncology

Professional Statement

Dr. Msaouel is a clinician and cancer biologist dedicated to translational research for the treatment of genitourinary malignancies. He received his MD and PhD in cellular and molecular physiology from the University of Athens in Greece. He then completed his internal medicine residency at the Albert Einstein College of Medicine / Jacobi Medical Center, and also served as Chief Resident for the program. He subsequently served as Chief Fellow at MD Anderson Cancer Center while completing his fellowship in medical oncology. His clinical interests are in the treatment of patients with renal cell and urothelial carcinomas, with a particular emphasis on rare variants such as renal medullary carcinoma. His laboratory research focuses on understanding the role of defects in subunits of the SWI/SNF chromatin remodeling complex, such as SMARCB1, in the biology of genitourinary malignancies. His clinical research involves developing and implementing novel clinical trial designs.